Stock Events

Stock Events

Cardiol Therapeutics (CRDL.TO) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.14

-0.13

-0.12

-0.11

Details

Expected EPS

-0.12062235080919598

Actual EPS

-0.14109999091999997

Surprise EPS

-0.02

Surprise Percent

+16.98%

Description

Cardiol Therapeutics (CRDL.TO) has reported earnings of -0.14109999091999997 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.